CliniGA CRO

CliniGA CRO Blog

Responding to a Missed Study Visit Without Blame

A missed visit does not prove that a participant lacks commitment.

Representative research photograph: Responding to a Missed Study Visit Without Blame
Photo: U.S. Navy photo by Journalist 1st Class Daniel J. Calderon. · License: Public domain · Cropped and resized.
Published
Updated

A missed visit does not prove that a participant lacks commitment. Initial contact can focus on safety and a feasible next step. Blaming language may discourage someone from sharing the real reason for absence and damage communication throughout the remainder of the study.

Define the workflow

Confirm approved communication preferences first. Situations potentially requiring clinical assessment should be referred to the investigator rather than interpreted by the coordinator. A replacement appointment depends on protocol windows and the effect of missed activities. Never create a record suggesting the original visit occurred.

Worked example

For example, an unexpected family caring responsibility prevents attendance. Staff leave a brief privacy-preserving message and offer a convenient time to speak. Once contact is established, they listen before explaining options reviewed by the investigator. They do not exaggerate consequences of lateness to pressure continued participation.

Practical checks

  • Avoid revealing study or health details in the first message beyond the person’s agreed preferences.
  • Obtain appropriate review of the safety and data implications of the missed visit.
  • Record attempted contact separately from reasons the participant has actually provided.

Decision and boundaries

A useful process makes the missed activity, assessment and agreed next step clear. Contact frequency and methods should follow the approved process and the person’s preferences. Being unreachable does not automatically demonstrate an intention to withdraw. On return, preserve voluntary choice and appropriate referral for care questions.

Frequently asked questions

Can a coordinator choose a replacement date independently?
Respect delegated authority and protocol conditions. Clinical or significant timing implications require appropriate investigator review.
Is an unreachable participant automatically withdrawn?
No. Consider the applicable study process, documented communication and investigator assessment rather than assuming a decision that was never expressed.

Sources

  1. EMA — ICH E6 Good Clinical Practice
  2. WHO — Guidance for best practices for clinical trials